These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15053415

  • 1. Memantine (Namenda) for moderate to severe Alzheimer's disease.
    Ables AZ.
    Am Fam Physician; 2004 Mar 15; 69(6):1491-2. PubMed ID: 15053415
    [No Abstract] [Full Text] [Related]

  • 2. Memantine hydrochloride.
    Witt A, Macdonald N, Kirkpatrick P.
    Nat Rev Drug Discov; 2004 Feb 15; 3(2):109-10. PubMed ID: 15040575
    [No Abstract] [Full Text] [Related]

  • 3. Alzheimer's disease and the glutamate NMDA receptor.
    Doraiswamy PM.
    Psychopharmacol Bull; 2003 Feb 15; 37(2):41-9. PubMed ID: 14566213
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
    Bullock R.
    Alzheimer Dis Assoc Disord; 2006 Feb 15; 20(1):23-9. PubMed ID: 16493232
    [Abstract] [Full Text] [Related]

  • 5. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT, Edwards KR, Zhao Q.
    J Clin Pharmacol; 2006 Jul 15; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [Abstract] [Full Text] [Related]

  • 6. [The clinical relevance of memantine use].
    Sobów T.
    Psychiatr Pol; 2004 Jul 15; 38(2):321-30. PubMed ID: 15307296
    [Abstract] [Full Text] [Related]

  • 7. Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease.
    Bassil N, Thaipisuttikul P, Grossberg GT.
    Expert Opin Pharmacother; 2010 Jul 15; 11(10):1765-71. PubMed ID: 20540654
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL, Lladó Plarrumaní A.
    Neurologia; 2005 Dec 15; 20(10):686-91. PubMed ID: 16317590
    [Abstract] [Full Text] [Related]

  • 9. Drugs for Alzheimer's disease.
    Cranwell-Bruce LA.
    Medsurg Nurs; 2010 Dec 15; 19(1):51-3. PubMed ID: 20336985
    [No Abstract] [Full Text] [Related]

  • 10. Memantine in moderate-to-severe Alzheimer's disease.
    Bleich S, Wiltfang J, Kornhuber J.
    N Engl J Med; 2003 Aug 07; 349(6):609-10; author reply 609-10. PubMed ID: 12904528
    [No Abstract] [Full Text] [Related]

  • 11. [The challenge of Alzheimer dementia].
    Pharm Unserer Zeit; 2003 Aug 07; 32(1):77. PubMed ID: 12577765
    [No Abstract] [Full Text] [Related]

  • 12. Memantine for dementia?
    Drug Ther Bull; 2003 Oct 07; 41(10):73-6. PubMed ID: 14593973
    [Abstract] [Full Text] [Related]

  • 13. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A, Alfaro V.
    Rev Neurol; 2003 Oct 07; 42(10):607-16. PubMed ID: 16703529
    [Abstract] [Full Text] [Related]

  • 14. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN.
    J Clin Psychiatry; 2006 Oct 07; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [Abstract] [Full Text] [Related]

  • 15. Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease.
    Grossberg GT, Pejović V, Miller ML, Graham SM.
    Dement Geriatr Cogn Disord; 2009 Oct 07; 27(2):164-72. PubMed ID: 19194105
    [Abstract] [Full Text] [Related]

  • 16. Memantine (Namenda, Forest Pharmaceuticals).
    Roman MW.
    Issues Ment Health Nurs; 2009 Mar 07; 30(3):202. PubMed ID: 19291500
    [No Abstract] [Full Text] [Related]

  • 17. Drug for moderate to advanced Alzheimer's approved.
    Mayo Clin Health Lett; 2004 Feb 07; 22(2):4. PubMed ID: 15032170
    [No Abstract] [Full Text] [Related]

  • 18. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
    Riepe MW, Adler G, Ibach B, Weinkauf B, Tracik F, Gunay I.
    Dement Geriatr Cogn Disord; 2007 Feb 07; 23(5):301-6. PubMed ID: 17356273
    [Abstract] [Full Text] [Related]

  • 19. [Antibodies, antihypertensive drugs, antioxidants. Can they prevent Alzheimer disease?].
    MMW Fortschr Med; 2003 Aug 21; 145(33-34):60. PubMed ID: 14526584
    [No Abstract] [Full Text] [Related]

  • 20. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL.
    J Clin Psychiatry; 2006 Aug 21; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.